newsinsights

Browse our recent blogs, articles and papers below and sign up here for our regular newsletter. 

20 medical companies in the race to defeat Corona Virus | WELL

Here is a brief description of how 20 constituents in the HAN-GINS Indxx Healthcare Innovation UCITS ETF (WELL) are involved in the fight against COVID-19:

  1. Regeneron Pharmaceuticals, Inc.

    Regeneron has identified hundreds of virus-neutralizing antibodies and have plans to initiate large-scale manufacturing by mid-April with an antibody cocktail therapy.  This biotech leader is at the forefront of the race to find a vaccine for COVID-19.  It is one of WELL’s largest 3 holdings (14th April 2020). [1]

  2. Smith & Nephew plc

    Smith and Nephew has a contract with the U.K. government to build a new ventilator specifically designed for the large-scale production needed to combat the spread of COVID-19. [2]

  3. QIAGEN NV

    The US Food and Drug Administration (FDA) has granted an emergency use authorization to Qiagen (NYSE:QGEN) for a diagnostic test that the company said can differentiate among COVID-19 and 20 other respiratory diseases [3]

  4. bioMerieux SA

    bioMérieux, a world leader in the field of in vitro diagnostics, has announced the forthcoming launch of three different tests to address the COVID-19 epidemic and to meet the different needs of physicians and health authorities in the fight against this emerging infectious disease. [4]

  5. Bio-Rad Laboratories, Inc. Class A

    Bio-Rad's products are used in research and clinical laboratories around the world, contributing to advancement of COVID-19 research, SARS-CoV-2 screening assays, and vaccine development. [5]

  6. BioTelemetry, Inc.

    BioTelemetry, Inc. (NASDAQ:BEAT), a leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, recently announced the activation of an expanded service using its Mobile Cardiac Outpatient Telemetry (MCOT(TM)) to monitor life-threatening QT prolongation in COVID-19 patients. [6]

  7. Boston Scientific Corporation

    Boston Scientific has collaborated with hospitals, universities and industry peers to find new and innovative ways to address the urgent demand for protective personal equipment (PPE) and ventilators. [7]

  8. DiaSorin S.p.A.

    DiaSorin Molecular LLC, a division of DiaSorin S.p.A., has received the Emergency Use Authorization (EUA) from the FDA for their Simplexa™ COVID-19 Direct kit. The kit provides a sample-to-answer test for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, directly from nasopharyngeal swab specimens. [8]

  9. Alnylam Pharmaceuticals, Inc

    Vir Biotechnology, Inc. (Nasdaq: VIR) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) has announced an expansion of their existing collaboration to include the development and commercialization of RNAi therapeutics targeting SARS-CoV-2, the virus that causes the disease COVID-19. [9]

  10. Avanos Medical, Inc.

    Avanos Medical is supporting the healthcare sector by adjusting production and working with their suppliers to produce more respiratory health products to help treat COVID-19 patients. [10]

  11. ResMed Inc.

    ResMed are focused on delivering the ventilation therapy that is essential to treat the respiratory complications of COVID-19. [11]

  12. Eiken Chemical Co., Ltd.

    Eiken Chemical Co., Ltd. (Headquarters: Taito Ward, Tokyo) is moving forward with the development of a reagent for detecting the COVID-19 coronavirus using the LAMP method*, a gene amplification method developed exclusively by Eiken Chemical. [12]

  13. Hologic, Inc.

    Hologic’s Molecular Test for the Novel Coronavirus, SARS-CoV-2, has received FDA emergency use authorization. [13]

  14. Luminex Corp

    In response to the global outbreak, Luminex has developed multiple solutions to enhance its NxTAG® and ARIES® testing offerings in order to automate and facilitate the detection of coronavirus. As a high-throughput, more comprehensive option, they have developed the NxTAG® CoV Extended Panel, which can detect SARS-CoV-2, and was authorized by the US FDA and Health Canada for Emergency Use Authorization (EUA). [14]

  15. Medtronic Plc

    Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its Medtronic Care Management Services (MCMS) business is launching two new solutions designed to help assess, monitor, and triage support for patients who may be concerned about COVID-19 and their respiratory symptoms. It has already launched its new Respiratory Infectious Disease Health Check to existing MCMS customers, and it is now launching a new COVID-19 Virtual Care Evaluation and Monitoring solution available to U.S. health systems, health plans and employers.  It is also helping with the production and delivery of more ventilators globally. [15]

  16. Meridian Bioscience, Inc.

    Meridian Bioscience, Inc. (NASDAQ: VIVO) announced that it has increased its commitment to the global fight against COVID-19 by making available zero cost samples of the company’s proprietary technologies to developers and manufacturers of molecular assays for COVID-19 detection. [16]

  17. Adaptive Biotechnologies Corp.

    Microsoft MSFT and Adaptive Biotechnologies ADPT recently extended their partnership in a bid to aid public health officials and researchers to access and track data pertaining to COVID-19 patient immune responses. [17]

  18. Health Catalyst, Inc.

    Health Catalyst’s growing suite of COVID-19 Solutions capabilities includes identifying the location of patients who have tested positive for COVID-19 as well as other patient, clinician and staff interactions and exposures to allow for infectious disease surveillance and automated monitoring for “hot-spots” using local geo-mapping. [18]

  19. Quidel Corporation

    The Lyra SARS-CoV-2 Assay is a real-time RT-PCR assay intended for the in vitro qualitative detection of human coronavirus SARS-CoV-2 from viral RNA extracted from nasopharyngeal (NP) or oropharyngeal (OP) swab specimens from patients with signs and symptoms of COVID-19. [19]

  20. Twist Bioscience Corp

    Twist Bioscience has partnered with Vanderbilt University Medical Center to supply critical products and identify antibody therapeutics for COVID-19. [20]

 

Article Date: 27/04/2020

Tell us how we can help